This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kern W, Haferlach C, Bacher U, Haferlach T, Schnittger S . Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity. Leukemia 2009; 23: 1361–1364.
Kroschinsky F, Schäkel U, Fischer R, Mohr B, Oelschlaegel U, Repp M et al. Cup-like acute myeloid leukemia: new disease or artificial phenomenon? Hematologica 2008; 93: 283–286.
Falini F, Nicoletti I, Martelli MF, Mecucci C . Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood. 2007; 109: 874–885.
Oelschlaegel U, Koch S, Mohr B, Schaich M, Falini B, Ehninger G et al. Rapid flow cytometric detection of aberrant cytoplasmic localization of nucleophosmin (NPMc) indicating mutant NPM1 gene in acute myeloid leukemia. Leukemia 2010; 24: 1813–1816.
Acknowledgements
We thank all participating study centers for including their patients in the SAL trials. The excellent skills of the technicians Claudia Garten, Marika Karger and Sandra Köhler, and of the data manager Catrin Theuser, are gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Oelschlaegel, U., Mohr, B., Schaich, M. et al. Reply to: ‘Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity’ by Kern et al.. Leukemia 25, 895–897 (2011). https://doi.org/10.1038/leu.2011.23
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.23